| NDC Code | 0179-0161-01 |
|---|
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0179-0161-01) |
|---|
| Product NDC | 0179-0161 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Venlafaxine Hydrochloride |
|---|
| Non-Proprietary Name | Venlafaxine Hydrochloride |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20141027 |
|---|
| End Marketing Date | 20200930 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA200834 |
|---|
| Manufacturer | KAISER FOUNDATION HOSPITALS |
|---|
| Substance Name | VENLAFAXINE HYDROCHLORIDE |
|---|
| Strength | 37.5 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
|---|